forbidden words: enhancing the diversity

enhancing

enhancing the present participle of enhance

enhance v enhanced, enhancing. 1 to raise to a higher degree; intensify; magnify: The candlelight enhanced her beauty.
Antonyms: lessen, diminish
2 to raise the value or price of: Rarity enhances the worth of old coins.
Antonyms: reduce

from — Dictionary.com | Meanings & Definitions of English Words. (2025i). In Dictionary.com.

~ ~ ~

diversity

diversity n 1 the state or fact of being diverse; difference; unlikeness: diversity of opinion.
Antonyms: similarity, sameness, resemblance

2 variety; multiformity.
Synonyms: multiplicity, heterogeneity, assortment, variation, dissimilarity, disagreement, contrast
Antonyms: homogeneity

3 a the spectrum of individual differences and the corresponding group memberships and identities that human beings have in society: A functioning multicultural society celebrates the diversity of its people, but diversity can also be problematic for the maintenance of a cohesive national identity.
b the inclusion of individuals representing more than one national origin, color, religion, socioeconomic stratum, sexual orientation, etc.: an initiative to increase diversity in the workplace.

4 a point of difference.

from — Dictionary.com | Meanings & Definitions of English Words. (2025i). In Dictionary.com.

~ ~ ~

enhancing diversity

Friends of Cancer Research (Friends) is proud to announce a new virtual meeting, Enhancing Diversity in Clinical Trials: Implementation of Diversity Plans: The U.S. Food and Drug Administration’s (FDA) draft guidance and the Food and Drug Omnibus Reform Act (FDORA) emphasize the importance of establishing diversity plans to ensure that clinical trials are more inclusive and investigational treatments are equally safe and effective across all populations. Discussions at this meeting will highlight insights and recommendations regarding the implementation of diversity plans, the use of various data sources, and current practices to establish enrollment goals for racial and ethnic diversity in clinical trials.
from — Enhancing diversity in clinical trials: Implementation of diversity Plans – Friends of Cancer Research. (2024, February 16). Friends of Cancer Research. 

Enhancing Diversity in STEM Careers Through Mentored Training (2024-2025): Despite the importance of diversity in STEM fields, underrepresented minorities make up only a small percentage of college graduates majoring in STEM. The environmental health field is particularly homogenous, an especially disturbing fact given the pervasiveness of environmental injustice and the relationship between environmental issues and health in topics like air pollutants and environmental toxins.
from — Connections, B. (2025, March 18). Enhancing diversity in STEM careers through mentored training (2024-2025). Bass Connections.

Enhancing Diversity and Inclusion in Clinical Trials
Abstract
Women and people from most racial and ethnic groups in the United States have historically been under-represented in clinical trials of investigational medical products. Inadequate representation of these groups may lead to an incomplete understanding of the safety and efficacy of new drugs, devices, biologics, and vaccines, and limit the generalizability of trial findings. As a result, new medical products may not be beneficial to all people who need them, and existing inequities in outcomes among various population groups may remain unchanged or worsen, or new disparities may arise. Although much work has focused on study-level strategies, research organizations must make systemic changes to how clinical trials are envisioned and implemented to achieve sustainable support for diversity and inclusion in clinical trials. The Clinical Trials Transformation Initiative (CTTI) conducted interviews with leaders at institutions that conduct clinical trials to explore perspectives on organizational-level practices that promote diversity and inclusion in clinical trials. Leaders described motivations, such as an ethical and moral imperative; organizational practices, such as staff investment and resource allocation; perceived return on investments, such as better science; and deterrents, such as cost and time. The CTTI also convened an expert meeting to discuss the interview findings and provide guidance. We present the interview findings and expert guidance in a framework that describes four key areas-commitment, partnerships, accountability, and resources-on sustaining organizational-level approaches for improving diversity and inclusion in clinical trials, with the ultimate goal of advancing health equity. Institutions who conduct and support clinical trials should implement organizational-level approaches to improve equitable access and diverse patient participation in clinical trials.

© 2023 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.
from — Corneli, A., Hanlen‐Rosado, E., McKenna, K., Araojo, R., Corbett, D., Vasisht, K., Siddiqi, B., Johnson, T., Clark, L. T., & Calvert, S. B. (2023). Enhancing diversity and inclusion in clinical trials. Clinical Pharmacology & Therapeutics, 113(3), 489–499. 

---

May 28, 2025
Flagstaff, Arizona

This is one of the words/ phrases you can’t say in the new Trump Administration. See a comprehensive list at the Forbidden Words Project.

image: red © Holly Troy 2025